GlassScriptPhysician profile
Carl Haupt
NPI 1114692936
$1,190.30
in general payments reported to CMS, 2019-2025
13 companies · $634 in 2025
The $634 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $556 · 2025: $634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $715 · Education: $448 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $715.38 |
| Education | $447.92 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beigene USA, INC. | $184.75 | 2024-2025 | Brukinsa |
| Incyte Corporation | $173.98 | 2024-2025 | |
| Janssen Biotech, INC. | $173.60 | 2024-2025 | Erleada, Akeega, Balversa |
| Astrazeneca Pharmaceuticals LP | $134.64 | 2024-2025 | Enhertu |
| Kite Pharma, INC. | $129.73 | 2025 | Yescarta |
| Astellas Pharma US INC | $99.00 | 2024 | |
| Beone Medicines USA, INC. | $80.12 | 2025 | Brukinsa |
| Aveo Pharmaceuticals, INC. | $74.99 | 2024 | |
| Janssen Scientific Affairs, LLC | $42.61 | 2025 | Erleada |
| Adc Therapeutics America, INC. | $31.27 | 2024 | |
| Becton, Dickinson and Company | $27.00 | 2024 | Site-Rite |
| Jazz Pharmaceuticals INC. | $21.01 | 2025 | |
| Genentech, INC. | $17.60 | 2025 | Tecentriq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Haupt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.